| Names | |
|---|---|
| Preferred IUPAC name 3-(2-Aminoethyl)-1H-indole-5,7-diol | |
| Other names 5,7-Dihydroxytryptamine | |
| Identifiers | |
3D model (JSmol) | |
| ChEMBL | |
| ChemSpider |
|
| ECHA InfoCard | 100.045.977 |
| EC Number |
|
| UNII | |
| |
| |
| Properties | |
| C10H12N2O2 | |
| Molar mass | 192.214 g/mol |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
5,7-Dihydroxytryptamine (5,7-DHT) is amonoaminergic neurotoxin[1][2] used in scientific research to decrease concentrations ofserotonin in the brain. The mechanism behind this effect is not well understood, but it is speculated to selectively destroyserotonergicneurons, in a manner similar to thedopaminergic neurotoxicity of6-hydroxydopamine (6-OHDA). What is known is that this compound is in fact not selective in depleting serotonin content, but also depletes norepinephrine. To selectively deplete serotonin stores, it is commonly administered in conjunction with desmethylimipramine (desipramine),[3] which inhibits the norepinephrine transporter.
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |